TIFFANY TRAN: Open Payments
NPI 1407518574 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 53 payments from 13 companies in 2025. Trend: 2023 $880 · 2024 $1,448 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $241 |
| AstraZeneca Pharmaceuticals LP | 7 | $216 |
| Kestra Medical Technology Services, Inc. | 16 | $166 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| BridgeBio Pharma, Inc. | 3 | $62 |
| CVRx, Inc. | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| ABIOMED | 1 | $26 |
Products named: WAINUA, LEQVIO, Assure WCD, Kerendia, Attruby, Barostim Neo System, ENTRESTO, ELIQUIS.
Industry payments across NC — which companies pay providers there.
